Immunotherapy before surgery shows promise for aggressive skin cancer
NCT ID NCT04315701
First seen Nov 20, 2025 · Last updated Apr 29, 2026 · Updated 17 times
Summary
This study tests whether giving the immunotherapy drug cemiplimab before surgery can help shrink high-risk skin cancers that haven't spread far. About 35 adults with certain types of squamous cell skin cancer will receive the drug and then have surgery. The goal is to see if this approach reduces the amount of cancer left behind and improves long-term control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT SKIN SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hoag Memorial Hospital
Newport Beach, California, 92663, United States
-
Los Angeles County-USC Medical Center
Los Angeles, California, 90033, United States
-
Northwestern University Feinberg School of Medicine
Chicago, Illinois, 60611, United States
-
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
-
University of Nebraska
Omaha, Nebraska, 68198, United States
Conditions
Explore the condition pages connected to this study.